Liberty One Investment Management’s CRISPR Therapeutics CRSP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-2,557
| Closed | -$120K | – | 156 |
|
|
2024
Q3 | $120K | Sell |
2,557
-148
| -5% | -$6.95K | 0.01% | 148 |
|
|
2024
Q2 | $146K | Buy |
2,705
+336
| +14% | +$18.1K | 0.02% | 150 |
|
|
2024
Q1 | $161K | Sell |
2,369
-1,047
| -31% | -$71.4K | 0.02% | 141 |
|
|
2023
Q4 | $214K | Buy |
3,416
+40
| +1% | +$2.5K | 0.03% | 121 |
|
|
2023
Q3 | $153K | Sell |
3,376
-272
| -7% | -$12.3K | 0.02% | 119 |
|
|
2023
Q2 | $205K | Sell |
3,648
-226
| -6% | -$12.7K | 0.03% | 118 |
|
|
2023
Q1 | $175K | Sell |
3,874
-38
| -1% | -$1.72K | 0.02% | 121 |
|
|
2022
Q4 | $159K | Hold |
3,912
| – | – | 0.02% | 121 |
|
|
2022
Q3 | $256K | Buy |
3,912
+2,237
| +134% | +$146K | 0.04% | 112 |
|
|
2022
Q2 | $271K | Sell |
1,675
-2,346
| -58% | -$380K | 0.05% | 117 |
|
|
2022
Q1 | $252K | Buy |
4,021
+1,407
| +54% | +$88.2K | 0.04% | 117 |
|
|
2021
Q4 | $198K | Buy |
2,614
+1,010
| +63% | +$76.5K | 0.03% | 127 |
|
|
2021
Q3 | $180K | Sell |
1,604
-71
| -4% | -$7.97K | 0.03% | 130 |
|
|
2021
Q2 | $271K | Buy |
1,675
+378
| +29% | +$61.2K | 0.05% | 124 |
|
|
2021
Q1 | $158K | Buy |
1,297
+339
| +35% | +$41.3K | 0.03% | 132 |
|
|
2020
Q4 | $147K | Sell |
958
-14
| -1% | -$2.15K | 0.03% | 112 |
|
|
2020
Q3 | $81K | Buy |
972
+358
| +58% | +$29.8K | 0.02% | 123 |
|
|
2020
Q2 | $45K | Buy |
+614
| New | +$45K | 0.01% | 116 |
|